Skip to content
  • Job Openings
  • Contact Us
Freenome Holdings, Inc. logo
Main Menu
  • Our Science
  • Clinical Expertise
    • Our Studies
    • Our Publications
  • Our Company
    • About Our Company
    • Leadership
    • Partnerships
  • Newsroom
  • Careers
    • Our Work
    • Job Openings
Freenome Holdings, Inc. logo
Main Menu
  • Our Science
  • Clinical Expertise
    • Our Studies
    • Our Publications
  • Our Company
    • About Our Company
    • Leadership
    • Partnerships
  • Newsroom
  • Careers
    • Job Openings
  • Contact Us
  • View All Posters

Plasma-derived cfDNA reveals potential biomarkers for response prediction and monitoring in NSCLC patients on immunotherapy

Vallania F, Assayag K, Ulz P, et al

Download
PrevOlderBlood-based detection of early-stage colorectal cancer using multiomics and machine learning
NewerEvaluation of a sensitive blood test for the detection of colorectal advanced adenomas in a prospective cohort using a multiomics approachNext
Categories
  • Presentations
  • Manuscripts

3300 Marina Boulevard
Brisbane, CA
94005

Contact Us

Privacy Policy

Terms of Use

Cookie Notice

Twitter X logo

©2025 Freenome Holdings, Inc. The following are registered trademarks of Freenome Holdings, Inc.: FREENOME®, PREEMPT CRC® and AI-EMERGE®. All rights reserved.

  • Services
  • About
  • Reviews
  • Why Us
  • Contact
  • Home
  • Services
  • About
  • Reviews
  • Why Us
  • Contact
  • Home